Panelists provide an overview of the EUROPA trial and its key findings.
HR+ SABCS 2024 Highlights
Panelists provide an overview of the TAILORx trial and its key findings.
Panelists provide an overview of the PADMA trial and its key findings.
Panelists provide an overview of the EMBER-3 trial and its key findings.
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Reanalysis of Glioblastoma Vaccine Trial Suggests Larger Survival Benefit
2
FDA Accepts NDA for Mezigdomide Combination in Relapsed/Refractory Multiple Myeloma
3
Dostarlimab Demonstrates Sustained Complete Responses in dMMR/MSI-H Rectal Cancer
4
What Long-Term Real-World Data on CAR T in Myeloma Could Reveal
5